Navigation Links
Wellcorps International Releases Breakthrough Multi-Benefit WellCapAM(TM) Activation Complex
Date:8/12/2008

SAN FRANCISCO, Aug. 12 /PRNewswire/ -- Following an overwhelmingly successful launch to healthcare practitioners over the past year, Wellcorps International, the leading innovator of multi-benefit health and wellness dietary supplements has announced its revolutionary WellCapAM(TM) Activation Complex is now available to the general public.

WellCapAM(TM) is a synergistic combination of 24 nutrients, antioxidants, and adaptogens that have proven in clinical studies to assist in promoting, maintaining and supporting cardiovascular health, respiratory and immune system health, optimum blood sugar levels, metabolic stimulation and appetite reduction.

"We designed WellCapAM(TM) to be your body's feel-good, energy-plus formula for the entire day," said Wellcorps CEO Tony Rich. "Most people experience a noticeable difference within the first 30 minutes of taking WellCapAM(TM). Within the first couple of days they realize they are more alert, eating less and adding more activities to their daily routine."

Combining the latest advancements in delivery, absorption and efficacy, WellCapAM's multiple benefit formulation includes exclusive extracts and organic botanicals that have been shown to lift the body's energy system, support increased circulation, reduce oxidative stress on cardiovascular tissues, provide powerful antioxidants to protect heart and vessel tissues, support more efficient absorption of dietary fats, and assist in the removal of environmental toxins.

Physicians utilizing WellCapAM(TM) in their practices have reported excellent results with their patient's increased energy without the traditional adrenal-depleting qualities of other energy-boosting supplements. WellCapAM(TM) users have also reported reduced joint pain and stiffness, increased circulation in extremities, reduced appetite and decreased belly fat.

"WellCapAM's unique formulation provides balancing adaptogenic herbs and essential nutrients that relieve str
'/>"/>

SOURCE Wellcorps International
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Wellcorps International Releases Major Paper on History and Evolution of Amphetamine and Anti-Depressant Use in America
2. Wellcorps International Unveils New Nutritional Supplements
3. Distinguished Cardiologists and Scientists Honored With 2008 International Academy of Cardiology Award
4. State of Ohio Recognizes Cincinnati Sub-Zero for Excellence in International Sales
5. Statement by the Service Employees International Union (SEIU) Concerning Allegations About SEIU Local 6434, United Long Term Care Workers Union
6. CPI International Announces Third Quarter 2008 Financial Results
7. Jesse Milan to Address 2008 International AIDS Conference
8. MINRAD International, Inc. to Discuss 2008 Second Quarter Financial Results on Thursday, August 14, 2008
9. Air Ambulance Company AirMed International Wins Multiple "Best in Business" Awards from Birmingham Business Journal
10. International AIDS Conference an Expensive Talking Shop Unless More Done for Children
11. Chindex International to Report Fiscal 2009 First Quarter Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...ate as a division of Xybion Corporation. , ...r 1, 2009 -- Xybion Corporation announced today th...ng assets of Quebec City based Amadeus Solutions, ...ce, risk, compliance and quality management softwa...e management organization headquartered in Montrea...
(Date:12/1/2009)..., MD was elected to the Stemedica Cell Technologie...rs at the Company’s November 20th Board Meet..., 2009 -- Anthony M. Marlon, MD was elected to the...dica”) Board of Directors at the Company&rsq...hD, Executive Chairman for Stemedica made the anno...
(Date:12/1/2009)...-- What many spa clients have thought for years, a...claimed in the 2009 AsiaSpa Awards: Thailand is in...ons including "Asian Spa Capital of the Year", Tha...Spa Awards, presented by AsiaSpa magazine, the reg..., during a glittering ceremony recently in Hong Ko...
(Date:12/1/2009)...lastography can help differentiate between cancero...y presented today at the annual meeting of the Rad...gh-frequency ultrasound with elastography has the ... diagnosis," said lead author Eliot L. Siegel, M.D... the University of Maryland School of Medicine (UM...
(Date:12/1/2009)...n-related injuries and deaths in the U.S. finds th...ospitals with aviation-related injuries annually, ...study, conducted by researchers from the Johns Hop...r Injury Research and Policy and Columbia Universi...tients were occupants of civilian, noncommercial p...
Breaking Medicine News(10 mins):Health News:Xybion Acquires Amadeus, a Leader in Governance, Risk, Compliance and Quality Management (GRC) Solutions 2Health News:Xybion Acquires Amadeus, a Leader in Governance, Risk, Compliance and Quality Management (GRC) Solutions 3Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 2Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 3Health News:Thailand - Spa Capital of Asia by Karen Emmons 2Health News:Thailand - Spa Capital of Asia by Karen Emmons 3Health News:Thailand - Spa Capital of Asia by Karen Emmons 4Health News:Thailand - Spa Capital of Asia by Karen Emmons 5Health News:Special ultrasound accurately identifies skin cancer 2Health News:More than 1,000 patients in US admitted annually for aviation-related injuries 2
... in vitro patients, fewer multiple pregnancies , ...rchers say DNA tests may be able to tell doctors w...F) are most likely to result in the births of heal...al multiple pregnancies in their IVF patients. , A...
...its five cities in one ...ounder and primary,teacher of the Institute for In... school, is hosting a public lecture series in fiv...he,challenges and opportunities that exist in Amer...
...erna Zentaris Inc.,(NASDAQ: AEZS ; TSX: AEZ), a g...ne therapy and oncology, today reported dosing has...ase 3 program with cetrorelix in benign,prostatic ...ndidate.,This 500-patient safety trial is the thir...
... /PRNewswire-FirstCall/,-- HeartWare Limited (ASX:... an investor presentation at the Seventh Annual JM...12:30 p.m. ET) on Wednesday, May 21, 2008. The,con... via a link provided at http://www.heartware.com ...
...ors has fine-tuned the dosage and timing for admin... (tPA) to patients with strokes caused by bleeding... week at the European Stroke Conference in Nice, F...s usually an 80 percent death rate in patients wit...
...d self esteem, SAUSALITO, Calif., May 14 When Pe...t a young woman was afraid to go to school,because...she took action.,Peggy donated two of her custom-m...y to pay for it., Brittany began losing her hair ...
Other Medicine News:Health News:DNA Fingerprinting Could ID Viable Embryos 2Health News:Institute for Integrative Nutrition Begins Road Tour 2Health News:AEterna Zentaris Announces First Patient Dosing for Safety Trial of Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia 2Health News:AEterna Zentaris Announces First Patient Dosing for Safety Trial of Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia 3Health News:AEterna Zentaris Announces First Patient Dosing for Safety Trial of Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia 4Health News:AEterna Zentaris Announces First Patient Dosing for Safety Trial of Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia 5Health News:HeartWare to Present at Seventh Annual JMP Securities Research Conference 2Health News:Researchers fine-tune clot-busting treatment for bleeding in brain 2Health News:Teen Girl Loses Hair But Gains Support 2
(Date:11/30/2009)...TTSDALE, Ariz., Nov. 30 ... of radiology solutions to radiology groups and ho...ted a redesigned Quality Assurance (QA) program to...adiologists and customers and to deliver superior ...an overview of the new QA program in several prese...
(Date:11/30/2009)...EW YORK, Nov. 30 Reportlinker.com ...ilable in its catalogue: ,, Outsourcing Opport... http://www.reportlinker.com/p0165747/Outsourcing...Report Description ,, Medical devices form one ...h an estimated size of $250 billion in 2009 and a ...
(Date:11/30/2009)...EL, N.J., Nov. 30 Me...f technology-enabled clinical documentation servic...adiological Society of North America (RSNA) confer...gy, the product leverages SpeechQ(TM), the company...ation used by thousands of radiologists. MedQuist...
Breaking Medicine Technology:NightHawk Radiology Launches Redesigned Quality Assurance Program 2Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 2Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 3Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 4Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 5Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 6Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 7Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 8Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 9MedQuist Features SpeechQ VTB for Radiology Solution at RSNA Convention 2Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 1Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 2Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 3Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 4Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 5Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 6Trius Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections 4560 1Trius Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections 4560 2Trius Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections 4560 3Trius Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections 4560 4Too Much Computer Gaming Can Steal Your Sleep 48151 1Too Much Computer Gaming Can Steal Your Sleep 48151 2Too Much Computer Gaming Can Steal Your Sleep 48151 3
...NESS WIRE)--May 17, 2007 - BioLineRx Ltd. (TASE:,B...nnounced today,that abstracts containing data from...s of BL-1020, first in class GABA-enhanced,antipsy...en,accepted for poster presentations at three lead...nted at the following,conferences:, -- Society of ...
...(BUSINESS WIRE)--May 18, 2007 - AVANT,Immunotherap...ve,preliminary results from an investigational dou...ating clinical trial of its,typhoid fever vaccine ...rchers found the single-dose, oral vaccine to be w...ccinated subjects,generating immune responses. Bas...
Other Medicine Technology:BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming,Clinical Conferences 2BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming,Clinical Conferences 3Avant's Typhoid Fever Vaccine Demonstrates Excellent Clinical,Potential 2Avant's Typhoid Fever Vaccine Demonstrates Excellent Clinical,Potential 3Avant's Typhoid Fever Vaccine Demonstrates Excellent Clinical,Potential 4Avant's Typhoid Fever Vaccine Demonstrates Excellent Clinical,Potential 5
11.50mm diameter Corneal Trephine Blades
9.25mm diameter Corneal Trephine Blades
8.50mm diameter Corneal Trephine Blades
8.00mm diameter Corneal Trephine Blades
Medicine Products: